A Short, Animated Storytelling Video to Boost Psychological Capital

May 9, 2023 updated by: PD Dr. Alexander Supady, University Hospital Freiburg

Efficacy of a Short, Animated Storytelling Video to Boost Psychological Capital in the Post-pandemic Era: a Randomized Controlled Trial

This study will evaluate the effect of a short, animated storytelling intervention video on positive psychological capital intervention on immediate and medium-term psychological capital and related constructs, gratitude and happiness. We will also measure voluntary engagement with the content of the short, animated storytelling intervention video on positive psychological capital.

In this 4-armed, parallel, randomized controlled trial, 10,000 adult, US participants will be randomly assigned to (1) a short, animated storytelling intervention video on positive psychological capital followed by the psychological capital , gratitude and happiness surveys (2) the surveys only, (3) an attention placebo control video followed by the before mentioned surveys, and (4) an arm that is exposed to neither the video nor the surveys. Two weeks later, participants in all four arms will complete all of the surveys.

The primary outcome is psychological capital (immediate and medium-term). Secondary outcomes are gratitude and happiness (immediate and medium-term) as well as voluntary engagement with the short, animated storytelling video content.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

10000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 59 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Registration with the Prolific platform

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Arm

At Time 1, the Intervention Arm will view a short, animated storytelling video designed to promote psychological capital and, immediately thereafter, complete the CPC-12R, the GQ-6 as well as a single-item validated happiness scale.

Two weeks later, the participants will complete the CPC-12R, the GQ-6 and the single-item validated happiness scale.

Participants in the Intervention Arm will view a short, animated storytelling video designed to promote psychological capital.
No Intervention: Scale-Exposed Control Arm

The Scale-Exposed Control Arm will watch no video content at Time 1, but will complete the CPC-12R, the GQ-6 as well as a single-item validated happiness scale.

Two weeks later, the participants will complete the CPC-12R, the GQ-6 and the single-item validated happiness scale.

Placebo Comparator: Attention Placebo Control Arm

The Attention Placebo Control Arm will view an attention placebo control video, unrelated to the outcomes measured in this trial, before completing the CPC-12R, the GQ-6 and the single-item validated happiness scale.

Two weeks later, the participants will complete the CPC-12R, the GQ-6 and the single-item validated happiness scale.

The Attention Placebo Control Arm will view an attention placebo control video, unrelated to the outcomes measured in this trial.
No Intervention: Un-exposed Control Arm

The Un-exposed Control Arm will neither watch video content, nor complete the CPC-12R, the GQ-6 and the single-item validated happiness scale at Time 1.

Two weeks later, the participants will complete the CPC-12R, the GQ-6 and the single-item validated happiness scale.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Immediate effect of the short, animated storytelling intervention video on positive psychological capital
Time Frame: immediately after watching the video
The immediate effect of the short, animated storytelling intervention video on positive psychological capital, as measured by the CPC-12R, the GQ-6 and the single-item validated happiness scale.
immediately after watching the video

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medium-term effect of the short, animated storytelling intervention video on psychological capital
Time Frame: 2 weeks
The medium-term effect of the short, animated storytelling intervention video on psychological capital after two weeks.
2 weeks
Immediate effect of the short, animated storytellingintervention video on gratitude and happiness
Time Frame: immediately after watching the video
The effect of the short, animated storytellingintervention video on gratitude and happiness, both related to the construct of positive psychological capital
immediately after watching the video
Medium-term effect of exposure to psychological capital and related psychological scales on these same outcomes
Time Frame: 2 weeks
The effect of exposure to psychological capital and related psychological scales on these same outcomes, measured two weeks later
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Till Bärnighausen, Prof. Dr., Heidelberg University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2023

Primary Completion (Anticipated)

July 31, 2023

Study Completion (Anticipated)

August 31, 2023

Study Registration Dates

First Submitted

January 30, 2023

First Submitted That Met QC Criteria

January 30, 2023

First Posted (Actual)

February 8, 2023

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Currently not planned. Individual requests may be directed to the corresponding author.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Capital

Clinical Trials on short, animated storytelling video (intervention video)

3
Subscribe